Correlation Between SCANSOURCE (SC3SG) and BioNTech

Can any of the company-specific risk be diversified away by investing in both SCANSOURCE (SC3SG) and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANSOURCE (SC3SG) and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SCANSOURCE and BioNTech SE, you can compare the effects of market volatilities on SCANSOURCE (SC3SG) and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANSOURCE (SC3SG) with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANSOURCE (SC3SG) and BioNTech.

Diversification Opportunities for SCANSOURCE (SC3SG) and BioNTech

-0.6

Correlation Coefficient

SCANSOURCE (SC3SG)  BioNTech

Excellent diversification

The 3 months correlation between SCANSOURCE and BioNTech is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding SCANSOURCE and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and SCANSOURCE (SC3SG) is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANSOURCE are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of SCANSOURCE (SC3SG) i.e., SCANSOURCE (SC3SG) and BioNTech go up and down completely randomly.

Pair Corralation between SCANSOURCE (SC3SG) and BioNTech

Assuming the 90 days trading horizon SCANSOURCE is expected to generate 0.97 times more return on investment than BioNTech. However, SCANSOURCE is 1.03 times less risky than BioNTech. It trades about 0.03 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.02 per unit of risk. If you would invest  3,520  in SCANSOURCE on July 24, 2025 and sell it today you would earn a total of  100.00  from holding SCANSOURCE or generate 2.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

SCANSOURCE  vs.  BioNTech SE

SCANSOURCE (SC3SG)

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SCANSOURCE are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, SCANSOURCE (SC3SG) is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

BioNTech SE

Risk-Adjusted Performance

Weakest

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BioNTech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with SCANSOURCE (SC3SG) and BioNTech

The main advantage of trading using opposite SCANSOURCE (SC3SG) and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANSOURCE (SC3SG) position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind SCANSOURCE and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.